Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
A-101 in Seborrheic Keratosis
NCT03148691Phase 2Completed
- Sponsor
- Aclaris Therapeutics, Inc.
- Start
- May 2017
- Primary completion
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of hydrogen peroxide gel in seborrheic keratosis (SK), sponsored by Aclaris Therapeutics, Inc.. Started May 2017; status: completed.
02
Drugs
hydrogen peroxide gel
03
Conditions
seborrheic keratosis (SK)
Beyond the preview
Go deeper on NCT03148691.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03148691.